Telemedicine Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flinders Medical Centre, Bedford Park, Australia
New research from Australia, the United States and Taiwan in the area of obesity detailed
September 13th, 2006
Investigators in Australia, the United States and Taiwan have published new obesity data. Study 1: A 6-week diet with Optifast Very Low Calorie Diet results in reductions in liver size and liver fat content. "Laparoscopic adjustable gastric banding (LAGB) requires surgical access to the gastroesophageal junction, which may be compromised by the enlarged, fatty liver that is frequently encountered in the obese. Liver size appears reduced and surgical access improved following preoperative weight loss with Optifast Very Low Calorie Diet (VLCD). The aim of this study was to assess the effects of 6 weeks Optifast VLCD on liver volume and fat content,"...
Source: Telemedicine Business Week (2006-09-13)
|
